🔎 Trials Near Me

መነሻ › የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ › ኢሊኖይ › Chicago

በChicago፣ IL ለየራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለየራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ የሚደረጉ 26 ጥናቶች በChicago እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Advocate Illinois Masonic Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06992427

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Captain James A Lovell Federal Health Care Center-VA North Chicago (Site # 133), Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06788990

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Chicago Hospital, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06465069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Exelixis Clinical Site #26, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05176483

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Chicago Comprehensive Cancer Center, Chicago
  • Advocate Illinois Masonic Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06589804

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Northwestern University, Chicago
  • University of Illinois, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05136196

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Rush University Medical Center Rush University Cancer Center Chicago, Chicago
  • The University of Chicago Medical Center (UCMC), Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07276399

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • The University of Chicago Medical Center (UCMC), Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06385080

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Northwestern University, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
እድሜ ከ18 እስከ 79 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT04671667

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Northwestern University Feinberg School of Medicine, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT05983432

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
  • Advocate Illinois Masonic Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT02734537

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Northwestern University Feinberg School of Medicine, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06163534

A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Chicago Medical Center /ID# 276638, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT07241039

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Northwestern University, Chicago
  • Rush MD Anderson Cancer Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT04333537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Northwestern University, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT06532279

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Northwestern University, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT07441681

SMP-3124LP in Adults With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Northwestern Medicine Cancer Center, Chicago
  • The University of Chicago, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT06526819

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • UChicago Medicine - River East, Chicago
  • The University Of Chicago, Chicago
  • University of Chicago Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT04389632

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • The University of Chicago Medical Center - Oncology, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT06747585

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
  • University of Chicago Medical Center /ID# 276271, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁን 2026 · NCT05005403

A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Chicago Comprehensive Cancer Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ሜይ 2026 · NCT05420948

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • The University of Chicago, Chicago
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ23 ኤፕሪ 2026 · NCT05893888

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Illinois Cancer Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ኤፕሪ 2026 · NCT06064877

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The University of Chicago, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ማርች 2026 · NCT05526924

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The University of Chicago Comprehensive Cancer Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT06778863

A Study of NX-1607 in Adults With Advanced Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Chicago, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2025 · NCT05107674

በሌሎች ከተሞች ለየራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ የሚደረጉ ጥናቶች

በChicago ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።